Ube, Japan

Masahiro Kojima

This inventor holds 6 USPTO granted patents and 1 EPO patent. Top assignees: Ube Industries, Inc., Ube Corporation. Active years: 2018-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masahiro Kojima. Retrieved from https://idiyas.com/inventor/masahiro-kojima-uby4j3vu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 83.3


Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018-2022

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Masahiro Kojima: Innovator in Pharmaceutical Compounds

Introduction

Masahiro Kojima is a prominent inventor based in Ube, Japan. He has made significant contributions to the field of pharmaceuticals, holding a total of 6 patents. His work focuses on developing innovative compounds that have potential applications in medicine.

Latest Patents

Kojima's latest patents include a range of substituted guanidine compounds. The present invention provides a compound of general formula (I), or a pharmacologically acceptable salt thereof, along with a pharmaceutical composition containing that compound. Another notable patent involves substituted dihydropyrrolopyrazole compounds. The methods of producing these compounds include various configurations of alkylene groups and hydrogen atoms, showcasing his expertise in chemical synthesis.

Career Highlights

Throughout his career, Masahiro Kojima has worked with notable companies such as Ube Industries, Inc. and Ube Corporation. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in pharmaceuticals.

Collaborations

Kojima has collaborated with talented individuals in his field, including Yusuke Shiraishi and Shigeru Ushiyama. These partnerships have fostered innovation and have been instrumental in the development of his patented compounds.

Conclusion

Masahiro Kojima's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through his patents and collaborations continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…